Ciccarese, Chiara https://orcid.org/0000-0002-3283-4339
Bauckneht, Matteo https://orcid.org/0000-0002-1937-9116
Zagaria, Luca
Fornarini, Giuseppe https://orcid.org/0000-0003-4754-6572
Beccia, Viria
Lanfranchi, Francesco https://orcid.org/0000-0002-6043-9627
Perotti, Germano
Pinterpe, Giada
Migliaccio, Fortuna
Tortora, Giampaolo https://orcid.org/0000-0002-1378-4962
Leccisotti, Lucia https://orcid.org/0000-0002-6000-2898
Sambuceti, Gianmario https://orcid.org/0000-0003-2979-6500
Giordano, Alessandro
Caffo, Orazio https://orcid.org/0000-0001-7968-2531
Iacovelli, Roberto https://orcid.org/0000-0002-1750-2117
Article History
Accepted: 13 November 2024
First Online: 29 November 2024
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Chiara Ciccarese has received speaker honoraria from Astellas, BMS, EISAI, IPSEN, Janssen, MSD, Novartis, Pfizer, and Sanofi. Matteo Bauckneht has received speaker honoraria from Novartis and GE Healthcare. Giampaolo Tortora is an advisory board member for BMS and Novartis. Luca Zagaria has received speaker honoraria from Novartis. Orazio Caffo has received speaker honoraria from Astellas, Astra Zeneca, Bayer, Janssen, Ipsen, MSD, Novartis, Pfizer, and Recordati. Roberto Iacovelli is an advisory board member for Astellas, BMS, EISAI, IPSEN, Janssen, MSD, Novartis, Pfizer, and Sanofi and a consultant for Astellas, EISAI, MSD, and Pfizer. Giuseppe Fornarini, Viria Beccia, Francesco Lanfranchi, Germano Perotti, Giada Pinterpe, Fortuna Migliaccio, Lucia Leccisotti, Gianmario Sambuceti, and Alessandro Giordano declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: All data generated or analyzed during this study are included in this published article and its supplementary information files.
: Not applicable.
: Conceptualization: C.C., M.B., and R.I. Data curation: L.Z., G.F., V.B., F.L., G.P., G.P., F.M., G.T., L.L., G.S., A.G., and O.C. Formal analysis: C.C., M.B., and R.I. Investigation: C.C., and M.B. Methodology: all authors. Software: C.C. and R.I. Writing - original draft: C.C., M.B., and R.I. Writing - review & editing: all authors.